CIK: 0001512848 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value ($000): $1,298,445 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 3,745,262 | $245,689 | 18.9% | $16.54 | +309.5% | COMMON STOCK | 03940C100 |
| — | VERONA PHARMA PLC | 2,688,565 | $170,697 | 13.1% | $8.67 | — | SPONSERED ADS | 925050106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,909,956 | $154,140 | 11.9% | $26.40 | +110.1% | COM | 76243J105 |
| TEM | TEMPUS AI INC | 2,615,979 | $126,195 | 9.7% | $33.09 | +63.1% | CL A | 88023B103 |
| COUR | COURSERA INC | 12,867,769 | $85,699 | 6.6% | $45.00 | -82.4% | COM | 22266M104 |
| TRVI | TREVI THERAPEUTICS INC | 11,370,376 | $71,520 | 5.5% | $2.46 | +94.1% | COM | 89532M101 |
| SVRA | SAVARA INC | 24,471,264 | $67,785 | 5.2% | $1.74 | +59.0% | COM | 805111101 |
| CRSP | CRISPR THERAPEUTICS AG | 1,587,854 | $54,035 | 4.2% | $20.40 | +107.8% | NAMEN AKT | H17182108 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 7,692,298 | $35,692 | 2.7% | $20.37 | -69.9% | COM | 61225M102 |
| AUPH | AURINIA PHARMACEUTICALS INC | 3,969,834 | $31,917 | 2.5% | $6.46 | +25.4% | COM | 05156V102 |
| MBX | MBX BIOSCIENCES INC | 3,614,486 | $26,675 | 2.1% | $22.87 | -53.8% | COM | 55287L101 |
| CVRX | CVRX INC | 2,026,083 | $24,779 | 1.9% | $28.00 | -49.6% | COM | 126638105 |
| ZBIO | ZENAS BIOPHARMA INC | 2,613,948 | $20,650 | 1.6% | $17.98 | -56.5% | COM | 98937L105 |
| GOSS | GOSSAMER BIO INC | 18,093,034 | $19,902 | 1.5% | $3.27 | -64.7% | COM | 38341P102 |
| KRRO | KORRO BIO INC | 1,090,793 | $18,991 | 1.5% | $33.32 | -11.0% | COM | 500946108 |
| — | NEUEHEALTH INC | 2,726,917 | $18,434 | 1.4% | $12.22 | — | COM NEW | 10920V404 |
| CSBR | CHAMPIONS ONCOLOGY INC | 1,713,720 | $14,875 | 1.1% | $6.16 | +64.4% | COM NEW | 15870P307 |
| SNTI | SENTI BIOSCIENCES INC | 3,775,615 | $12,686 | 1.0% | $3.75 | +3.9% | COM NEW | 81726A209 |
| CELC | CELCUITY INC | 1,250,001 | $12,638 | 1.0% | $10.24 | +10.5% | COM | 15102K100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,960,169 | $12,290 | 0.9% | $10.51 | -42.3% | COM | 71722W107 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,195,545 | $12,251 | 0.9% | $10.90 | -19.8% | COM | 68622P109 |
| — | REGULUS THERAPEUTICS INC | 6,467,802 | $11,319 | 0.9% | $1.57 | — | COM | 75915K309 |
| — | DESKTOP METAL INC | 1,439,892 | $7,070 | 0.5% | $4.13 | — | COM CL A | 25058X303 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 4,448,757 | $6,896 | 0.5% | $23.88 | -91.2% | COM | 09203E105 |
| NKTX | NKARTA INC | 3,568,781 | $6,567 | 0.5% | $26.42 | -92.2% | COM | 65487U108 |
| BZFD | BUZZFEED INC | 2,512,103 | $5,351 | 0.4% | $2.11 | +13.1% | CL A NEW | 12430A300 |
| IVA | INVENTIVA SA | 1,462,586 | $4,300 | 0.3% | $7.21 | — | ADS | 46124U107 |
| SYBX | SYNLOGIC INC | 2,922,772 | $3,624 | 0.3% | $2.94 | -53.7% | COM NEW | 87166L209 |
| — | X4 PHARMACEUTICALS INC | 14,986,793 | $3,543 | 0.3% | $1.51 | — | COM | 98420X103 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 17,079,778 | $3,365 | 0.3% | $8.44 | — | SPONDS ADR | 00653A107 |
| — | INOZYME PHARMA INC | 2,437,689 | $2,218 | 0.2% | $26.29 | — | COM | 45790W108 |
| OKUR | ONKURE THERAPEUTICS INC | 478,548 | $2,058 | 0.2% | $15.14 | -62.9% | COM CL A | 68277Q105 |
| MRKR | MARKER THERAPEUTICS INC | 1,625,678 | $2,000 | 0.2% | $2.77 | -34.0% | COM NEW | 57055L206 |
| — | ALLAKOS INC | 6,147,260 | $1,399 | 0.1% | $19.41 | — | COM | 01671P100 |
| — | IKENA ONCOLOGY INC | 600,063 | $768 | 0.1% | $2.54 | — | COM | 45175G108 |
| AFMDQ | AFFIMED N V | 442,648 | $320 | 0.0% | $5.69 | -82.1% | ORDINARY SHS NEW | N01045207 |
| UP | WHEELS UP EXPERIENCE INC | 106,125 | $107 | 0.0% | $3.53 | -61.0% | COM CL A | 96328L205 |